PlexoZome logo with a stylized letter P in red and Z in blue followed by the word PlexoZome in blue text. clinically proven liposomes

Targeted Delivery

Liposomal Technology

PlexoZome® is a scientifically proven complex liposomal technology. Our genuine liposomes are verified through TEM and Cryo-TEM imaging, Zeta potential and DLS testing. PlexoZome® formulations are made on site in our licensed facility, as such they are fully customisable stable liposomal ingredients.

PlexoZome® advantages

  • targeted delivery

  • scientifically validated genuine liposomes through TEM and Cryo-TEM imaging

  • fully customisable particle size, with DLS testing

  • improved stability, verified with Zeta Potential testing

  • supplied ready to use

  • Australian developed and made

PlexoZome liposome

Published Studies

PlexoZome® Curcumin modulates the synergistic role of EpCAM and estrogen receptor alpha.

This study delves into the in vitro potential of liposomal therapeutics utilising PlexoZome® Curcumin in targeting EpCAM/TROP1 and Estrogen Receptor Alpha (ERα) signalling pathways for LC management.

The effect of topical Palmitoylethanolamide (PlexoZome® Levagen) on Relief of post exercise joint knee pain.

Human studies have shown the effectiveness of PEA for joint pain. This study aimed to assess the effectiveness of a topical PEA (PlexoZome Levagen) spray on relieving knee joint pain post-exercise.

Scientific illustration of cells with round shapes, some with dark centers and smaller colored dots on a light pink background.

PlexoZome® is a trademark owned exclusively by Pharmako Biotechnologies Pty. Ltd., registered in Australia and other countries.